CSL Behring LLC, a global leader in biopharmaceuticals, is headquartered in the United States and operates extensively across North America, Europe, and Asia-Pacific. Founded in 1904, the company has established itself in the industry by focusing on innovative therapies for rare and serious medical conditions, particularly in immunology, haematology, and respiratory care. CSL Behring is renowned for its core products, including immunoglobulins and clotting factor therapies, which are distinguished by their high quality and efficacy. The company’s commitment to research and development has led to significant advancements in patient care, solidifying its position as a trusted provider in the biopharmaceutical market. With a strong emphasis on patient-centric solutions, CSL Behring continues to achieve notable milestones, enhancing the lives of patients worldwide.
We don't have data for CSL Behring LLC, but we can show you information about their parent organization instead.
View parent company